drugset / Trial / NCT00531856
Safety and Tolerability Study of Inhaled Carbon Monoxide in Kidney Transplant Patients
RandomizedParallel-groupSingle-blindBasic science
Summary
The purpose of this study is to evaluate the safety and tolerability of two carbon monoxide doses when administered as an inhaled gas for 1 hour in patients receiving kidney transplants.
Timeline
- Start
- 2007-08
- Primary completion
- 2011-08
- Completion
- 2011-08
Outcome
Outcome not reported
Stopped: “Clinical Hold pending additional data review and protocol amendment”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | carbon monoxide | Other / unclassified | 0.7 mg/kg | Inhaled |
| Subject | carbon monoxide | Other / unclassified | 2 mg/kg | Inhaled |
| Subject | carbon monoxide | Other / unclassified | 3 mg/kg | Inhaled |
| Subject | carbon monoxide | Other / unclassified | 3.5 mg/kg | Inhaled |
Indications
No indication recorded.